MEDAG is a novel adipogenesis gene involved in visceral obesity that is strongly associated with the onset and progression of type 2 diabetes (Yang and Yu, 2021) and can increase the risk of obesity (D'Angelo et al., 2018), which is related to the development and rupture of AAA. Here, MEDAG is linked to obesity disorder.